Biologics and Biosimilars as Treatment Options for Psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
| Hlavní autor: | Moya, Amena Khatun |
|---|---|
| Další autoři: | Kabir, Dr. Eva Rahman |
| Médium: | Diplomová práce |
| Jazyk: | en_US |
| Vydáno: |
Brac University
2023
|
| Témata: | |
| On-line přístup: | http://hdl.handle.net/10361/17712 |
Podobné jednotky
-
Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
Autor: Akter, Anika
Vydáno: (2022) -
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Autor: Islam, Nahidul
Vydáno: (2023) -
Detection of skin diseases using deep learning
Autor: Shodoy, Masuk Ur Rahman
Vydáno: (2024) -
Biosimilar in lymphoma treatment
Autor: Tanisha, Mehrin Haque
Vydáno: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
Autor: Tabassum, Turana
Vydáno: (2022)